- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/46 - Two or more oxygen, sulfur or nitrogen atoms
Patent holdings for IPC class C07D 239/46
Total number of patents in this class: 119
10-year publication summary
|
9
|
5
|
7
|
4
|
4
|
6
|
3
|
1
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2721 |
4 |
| Gilead Sciences, Inc. | 2106 |
4 |
| Vertex Pharmaceuticals Incorporated | 1630 |
3 |
| ADAMA Makhteshim Ltd. | 531 |
3 |
| Emory University | 1664 |
3 |
| Lek Pharmaceuticals d.d. | 198 |
3 |
| Memorial Sloan-Kettering Cancer Center | 1992 |
3 |
| Acea Therapeutics, Inc. | 29 |
3 |
| Novartis AG | 10612 |
2 |
| F. Hoffmann-La Roche AG | 7937 |
2 |
| The Regents of the University of California | 20303 |
2 |
| Boehringer Ingelheim International GmbH | 4636 |
2 |
| British Columbia Cancer Agency Branch | 188 |
2 |
| Eli Lilly and Company | 3926 |
2 |
| Flamma S.p.A. | 18 |
2 |
| Janssen Sciences Ireland UC | 181 |
2 |
| Modernatx, Inc. | 1288 |
2 |
| Purdue Pharmaceutical Products L.P. | 31 |
2 |
| Shionogi & Co., Ltd. | 836 |
2 |
| Socpra Sciences et Genie S.E.C. | 205 |
2 |
| Other owners | 69 |